p53 controls the A3B expression [149,150] and since ER− tumours are enriched for inactivating p53 mutations [137,151], this could contribute to elevated levels of A3B expression in this type of tumour that is significantly higher compared with ER+ breast tumours. Here, APOBEC3B is linked to neoplasm.